As for targeted therapy, studies have shown that PARP1 is highly expressed on mRNA and protein levels in SCLC, and SCLC was significantly sensitive to PARPi, which enhanced the efficacy of chemotherapy.13 This evidence concerns the gene PARP1 and small cell lung carcinoma.